-
Mashup Score: 4Potassium-Competitive Acid Blockers and Proton Pump Inhibitors: The Dynamic Duo of Acid Blockers – Gastroenterology & Hepatology - 1 month(s) ago
Corey J. Ketchem, MD Division of Gastroenterology and Hepatology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Kristle L. Lynch, MD Division of Gastroenterology and Hepatology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Corresponding author: Kristle L. Lynch, MD Perelman Center for Advanced Medicine 750 – South Pavilion 3400 Civic Center Blvd Philadelphia, PA 19104 Tel: (215)
Categories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 8Management of Overweight and Obesity in Patients With Inflammatory Bowel Disease – Gastroenterology & Hepatology - 1 month(s) ago
Mark Shneyderman, BS Icahn School of Medicine at Mount Sinai Hospital, New York, New York Hannah Freid, BA Icahn School of Medicine at Mount Sinai Hospital, New York, New York David Kohler, MD Department of Pediat rics, Icahn School of Medicine at Mount Sinai, New York, New York Jellyana Peraza, MD The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York Natasha Haskey, PhD, RD Department of Biology, The University of British Columbia, Okanagan
Categories: General Medicine News, GastroenterologyTweet-
“Management of Overweight and Obesity in Patients With Inflammatory Bowel Disease” by Mark Shneyderman, BS and colleagues. https://t.co/OmWJI7k7xJ @JellyanaPeraza @nhaskeyRD @AsherKornbluth @GimdGold @IcahnMountSinai @mountsinaiNYC @CalDomMed @UBC
-
-
Mashup Score: 1Current Issue – Gastroenterology & Hepatology - 2 month(s) ago
Abstract: Tremendous effort has been put forth over the past 2 decades in understanding the pathophysiology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH). Although multiple potential […] Abstract: Barrett esophagus (BE) is the only known precursor to esophageal adenocarcinoma (EAC), a cancer that continues to have a poor 5-year survival rate of 20%. […] G & H What led to the concept of a treat-to-target approach for the management of patients with inflammatory bowel
Categories: General Medicine News, GastroenterologyTweet-
The latest issue of Gastroenterology & Hepatology is now available online https://t.co/GtoiDSlzRi #gastroenterology #hepatology
-
-
Mashup Score: 0Inflammatory Bowel Disease and Cardiovascular Disease – Gastroenterology & Hepatology - 3 month(s) ago
Remo Panaccione, MD Professor of Medicine University of Calgary CCC Chair in IBD Research Director, Inflammatory Bowel Disease Unit Director, Gastrointestinal Research Cumming School of Medicine University of Calgary Calgary, Alberta, Canada G & H What studies have shown a link between inflammatory bowel disease and cardiovascular disease? RP Several epidemiologic studies have shown that inflammatory bowel disease (IBD) is associated with an increased risk of a variety of cardiovascular diseases, including
Categories: General Medicine News, GastroenterologyTweet-
“Inflammatory Bowel Disease and Cardiovascular Disease” with Remo Panaccione, MD https://t.co/yfoUX4aOUX @Rpanaccione @CalDomMed #cardiovasculardisease #IBD
-
-
Mashup Score: 0Management of Gastric Varices Using Retrograde Transvenous Obliteration Procedures – Gastroenterology & Hepatology - 3 month(s) ago
Edward Wolfgang Lee, MD, PhD Professor Interventional Radiology, Liver Transplant Surgery, and Space Medicine UCLA Medical Center David Geffen School of Medicine at UCLA Los Angeles, California G & H When should retrograde transvenous obliteration be considered in the management of gastric varices? EL Gastric varices are the second most common type of varices in patients with end-stage liver disease and develop in approximately 30% of patients with portal hypertension. Medical management should be the
Categories: General Medicine News, GastroenterologyTweet-
“Management of Gastric Varices Using Retrograde Transvenous Obliteration Procedures” with Edward Wolfgang Lee, MD, PhD https://t.co/55CpDTA0A4 @EdLeeUCLAIR
-
-
Mashup Score: 0Remote Monitoring for Patients With Inflammatory Bowel Disease: Current Status and the Future of the Field – Gastroenterology & Hepatology - 3 month(s) ago
Michelle D. Dong, BMSc, MMSc Geisel School of Medicine at Dartmouth, Hanover, New Hampshire Jessica K. Salwen-Deremer, PhD Geisel Sc hool of Medicine at Dartmouth, Hanover, New Hampshire Center for Digestive Health, Section of Gastroenterology and Hepatology, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 3Department of Psychiatry, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire Corey A. Siegel, MD, MS Geisel School of Medicine at Dartmouth, Hanover, New Hampshire Center for Digestive
Categories: General Medicine News, GastroenterologyTweet-
“Remote Monitoring for Patients With Inflammatory Bowel Disease: Current Status and the Future of the Field” by Michelle D. Dong, BMSc, MMSc, Jessica K. Salwen-Deremer, PhD, and Corey A. Siegel, MD, MS https://t.co/mmx3bv7ORL
-
-
Mashup Score: 0Insights Into Combination Therapy for Metabolic Dysfunction-Associated Steatohepatitis – Gastroenterology & Hepatology - 3 month(s) ago
Michael Charlton, MBBS Professor of Medicine Director, Transplant Institute The University of Chicago Medicine Chicago, Illinois G & H What are the main reasons for using combination therapy for metabolic dysfunction-associated steatohepatitis? MC Given the current landscape of efficacy across the different agents that have been studied in metabolic dysfunction-associated steatohepatitis (MASH), including the agent that was recently approved, the most important reason for using combination therapy is to
Categories: General Medicine News, GastroenterologyTweet-
“Insights Into Combination Therapy for Metabolic Dysfunction-Associated Steatohepatitis” with Michael Charlton, MBBS https://t.co/8h5OqOmfwe @mcharltonmd @UchicagoMed
-
-
Mashup Score: 0Nonendoscopic Testing for Esophageal Precancer in an At-Risk Population – Gastroenterology & Hepatology - 3 month(s) ago
Dan Lister, MD Director, Arkansas Heartburn Treatment Center President-Elect, American Foregut Society Heber Springs, Arkansas G & H What are the challenges of the current national society screening strategy for Barrett esophagus? DL One major problem is that there are 3 sets of US guidelines, from the American Gastroenterological Association (AGA), the American College of Gastroenterology, and the American Society for Gastrointestinal Endoscopy, with different recommendations on who should be screened
Categories: General Medicine News, GastroenterologyTweet-
“Nonendoscopic Testing for Esophageal Precancer in an At-Risk Population” with Dan Lister, MD https://t.co/fr53mpvZGc @StopMyReflux
-
-
Mashup Score: 0Continuing the Dialogue in IBS-C Management: Importance of Individualizing Care and Tailoring Treatment – Gastroenterology & Hepatology - 3 month(s) ago
Brennan Spiegel, MD, MSHS Professor of Medicine and Public Health Director of Health Services Research Director, Master’s Degree Program in Health Delivery Science Site Director, Clinical and Translational Science Institute Cedars-Sinai Medical Center Los Angeles, California A 28-year-old woman presents to her primary care physician with a history of straining and painful defecation, sense of incomplete evacuation, and bothersome abdominal pain that improves with bowel movements. These symptoms have
Categories: General Medicine News, GastroenterologyTweet-
“Continuing the Dialogue in IBS-C Management: Importance of Individualizing Care and Tailoring Treatment” with Brennan Spiegel, MD, MSHS https://t.co/g3VbR5HPKr @BrennanSpiegel @CedarsSinai
-
-
Mashup Score: 1Rationale for an Eosinophilic Esophagitis Treat-to-Target Concept – Gastroenterology & Hepatology - 3 month(s) ago
Thomas Greuter, MD Department of Gastroenterology and Hepatology, University Hospital of Zurich, Zurich, Switzerland Department of Internal Medicine, GZO – Zurich Regional Health Center, Wetzikon, Switzerland Division of Gastroenterology and Hepatology, Lausanne University Hospital – CHUV, Lausanne, Switzerland Alex Straumann, MD Department of Gastroenterology and Hepatology, University Hospital of Zurich, Zurich, Switzerland Corresponding author: Thomas Greuter, MD Assistant Professor Department of
Categories: General Medicine News, GastroenterologyTweet-
“Rationale for an Eosinophilic Esophagitis Treat-to-Target Concept” by Thomas Greuter, MD, and Alex Straumann, MD https://t.co/ZoGyrZ6RLN
-
“Potassium-Competitive Acid Blockers and Proton Pump Inhibitors: The Dynamic Duo of Acid Blockers” by Corey J. Ketchem, MD, Kristle L. Lynch, MD, and Mazen Noureddin, MD, MHSc https://t.co/SxwdoMpOQg @cjketc2 @penngihep